University of Cambridge's MRC Toxicology Unit is recruiting a Research Associate to study how modified mRNA and antisense oligonucleotide therapeutics activate innate immune pathways, building mechanistic cellular-immunology, RNA-biology, and translational-toxicology models to improve therapeutic safety. Requires a PhD (or near completion) in immunology, RNA biology, or molecular cell biology. Deadline 13 Oct 2026.
Text as published by the employer. Always confirm details on the employer's site.